Chat real-time with other investors about CSSV, by clicking this link: http://www.stockwire.com/CSSV
Caspian Services, Inc. (OTCBB: CSSV) announced today that the European Bank for Reconstruction and Development ("EBRD") and Balykshi LLP ("Balykshi") have entered into agreements to increase the potential financial commitment of EBRD to help fund the development of a private-sector marine base being developed by Caspian. Balykshi is a wholly-owned subsidiary of Caspian Real Estate Limited which is a wholly-owned subsidiary Caspian.
Chat real-time with other investors about AMXG, by clicking this link: http://www.stockwire.com/AMXG
AmMex Gold Mining Corp. (OTCBB: AMXG) is pleased to announce that we have closed a non-brokered private placement financing of $700,000 US at a price of $0.55 a share. There were no warrants or finders fees attached to this financing. The funds will be used to continue their ongoing exploration and drill programs.
Chat real-time with other investors about DORB, by clicking this link: http://www.stockwire.com/DORB
DOR BioPharma, Inc. (OTCBB: DORB) announced today that the European Patent Office has granted a patent, EP 1024827 B1, with claims related to oral vaccination using mutated non-toxic forms of botulinum neurotoxin as a vaccine to prevent exposure to botulinum toxin. The European patent follows the issuance of a patent in the United States, U.S. 6,051,239, which was granted in April, 2000 and contains equivalent claims for oral vaccination. DOR has exclusively licensed these issued patents and related patent applications from Thomas Jefferson University.
As the saying goes...follow the money!
To see the complete Movers & Shakers Blog go to: http://www.stockwire.com .
About Stockwire:
Stockwire is a company that is pioneering a new way to research companies before you invest them. It's called a Stockumentary. A Stockumentary is a documentary on a publicly traded company. Imagine a Dateline NBC segment, but on a publicly traded company. We are the first company to ever bring this type of quality research to investors in this format.
